Evolving dynamics demand an evolving approach. One which places emphasis on understanding the opportunity areas, thinking ahead and working diligently towards creating the processes appropriate for a challenging road map. Pharma at Vivimed has this at its core. There are CGMP facilities, different business models, contract manufacturing and looking at new drug launches in the branded space. In fact Vivimed has identified over half a dozen drugs and has filed the necessary dossiers to sell in Russia and the Ukraine.